← Back to Search

Behavioral Intervention

Pro2col Health App for Improving Health Behaviors

Tampa, FL

N/A

Waitlist Available

Research Sponsored by Applied Science & Performance Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Daily steps < 5,000

Male or female, aged 21-60 years

Must not have

History or current diagnosis of suicidal thoughts/ideation

Insulin-dependent diabetes and/or metformin use

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6-weeks

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if a new smartphone app called Pro2col Health can improve the health outcomes and behaviors of healthy middle-aged adults."

See full description

Who is the study for?

This trial is for healthy middle-aged adults (21-60 years) who are slightly overweight, can perform physical tasks, and own a smartphone. They must be willing to use the Pro2col app connected to Apple Health or Google Fit and track their steps. Excluded are those with serious illnesses, drug abuse history, mental health issues, certain medication use, recent injuries or surgeries.Check my eligibility

What is being tested?

The study tests the effectiveness of the Pro2col Health smartphone application on improving health behaviors and motor skills in adults. Participants will follow the app's protocol while their activity is tracked via smartphone sensors to measure changes in nutrition habits and physical abilities.See study design

What are the potential side effects?

Since this trial involves using a smartphone application for tracking health behaviors rather than a medical treatment or drug intervention, there are no direct side effects associated with traditional clinical trials. However, participants may experience fatigue from increased physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I walk less than 5,000 steps a day.

show original

Select...

I am between 21 and 60 years old.

show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have had or currently have thoughts about suicide.

show original

Select...

I use insulin or metformin for my diabetes.

show original

Select...

I have chronic kidney or liver disease.

show original

Select...

I have been diagnosed with depression.

show original

Select...

I have not smoked or vaped in the last 14 days.

show original

Select...

I do not have any uncontrolled heart or blood vessel diseases.

show original

Select...

I have used supplements or performance enhancers other than caffeine in the last 30 days.

show original

Select...

I have or had cancer before.

show original

Select...

I am currently undergoing chemotherapy or radiation treatments.

show original

Select...

I have a musculoskeletal condition like muscular dystrophy or arthritis.

show original

Select...

I understand the study details and can follow its requirements.

show original

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6-weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6-weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Biological Age

Blood Pressure

Body Composition

+3 more

Secondary study objectives

Depression

Quality of Life

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Pro2colExperimental Treatment1 Intervention

The experimental group will be enrolled in the Prime Health Technologies software (Pro2col), which provides a digital diagnostic score to calculate healthspan and biological age, along with AI and group community-based coaching dynamics. Subjects will be assigned a 6 week progressive protocol targeting improvements in daily activity levels, nutritional awareness, and overall lifestyle risk factors.

Group II: ControlActive Control1 Intervention

The control group will receive subject-facing materials depicting current general activity recommendations as published by the American Heart Association (AHA) and current dietary guidelines provided by the United States Department of Agriculture (USDA).

0 / 13Eligibility criteria met